In a market dominated by billion-dollar conglomerates, BioMedomics is executing a surgical strike on one of medicine's most persistent blind spots. Their weapon: Sickle SCAN, the world's first rapid point-of-care test for sickle cell disease.

"They're not building a better lab test—they're eliminating the lab entirely."

The tech stack tells another story. jQuery, Bootstrap, and Tailwind CSS—these aren't the tools of a unicorn. They're pragmatic choices for a company that ships diagnostic hardware, not SaaS. No fancy React frameworks, no headless CMS. Their stack says: 'We build medical devices, not web apps.' The 14 technologies detected include Priority Hints and Lazy Loading—performance optimizations that matter when doctors in rural Africa load their site on 3G connections.

• Revenue per employee: $152,941—healthy for a hardware/medical company
• Social presence across 5 platforms, but LinkedIn is their professional anchor
• Zero funding data listed suggests bootstrapped or strategic partnerships
• Top 10M global rank is irrelevant when your buyers are in procurement offices